D & D BioTech Farms, LLC
DBA
.png)
Pioneering Ethical Biotechnology Solutions
Overview
Our Vision
D & D BioTech Farms specializes in sustainable and ethical biotechnological practices.
We focus on crafting the highest quality mucin using lab-grown snails, revolutionizing the cosmetic and pharmaceutical industries.
Rendering
of 1000 sq ft food grade processing room
Our commitment to zero waste and cruelty-free methods ensures that we not only provide top-notch products but also contribute positively to the environment.
At D & D BioTech Farms, we believe in harmonious innovation.
One of SIX
OG - Gen 1
Helix Aspersa
Innovation
We employ cutting-edge technology in innovative heliciculture, or snail farming, ensuring the production of the highest quality mucin without harm.
Our gentle harvesting methods preserve the bioactive properties essential for cosmetics and pharmaceuticals, while maintaining ethical standards.
Our bio-technical farming practices promote sustainability by utilizing every part of the snail. From escargot sales to calcium-rich compost from shells, this zero-waste philosophy highlights our commitment to environmental responsibility.
We remove snails from local Ohio farms by harvesting them ethically, and bring them back to D & D BioTech Farms, LLC to be added to our breeding crops. We geo-tag the locations in order to track the breeding, to maintain consistency.
Our Philosophy
“Ethical sourcing is not just a practice; it's our promise to the environment and future generations.”
Us....
Cassidie 'Dee' Gregory
CEO - CFOO
Cruelty- Free Operations Officer
J, Andrew 'Drew' Gregory
CFO - COO
Chief Operations Officer
D & D BioTech Farms
With Cassidie's leadership and precision decision making, we are growing into the largest heliciculture in the United States.
​
​
Drew has over 20 years experience in machine engineering and design, and will continue to refine the manufacturing processes to meet all the quality standards needed for ethical mucin harvesting.
Why Snails...
THE INDUSTRY PROBLEM
​
Import Dependency
The U.S. has ZERO large scale, cruelty-free, mucin producers. None.
The United States relies on imports for 99.9% snail mucin, mainly from South Korea, Europe, Thailand, and Nigeria.
​
Extraction Quality Issues
High-stress extraction methods increase mucin quantity, but lower product quality and ethical standards.
Some producers still use a kill method to this day.
Ethical Transparency Gap
Lack of transparency in the industry raises ethical concerns despite labels claiming cruelty-free status.
No farms are offering video transparency.
Our Solution
Ethical Sourcing Practices
Ethical harvesting from local Ohio Farms
Sustainable Farming Environment. Zero waste.
Meat can be sold as escargot, or used in animal feed.
Shells can be ground for calcium compost.
​​​​
High-Quality Mucin Harvesting
Leadership in Sustainable Beauty
Cruelty-free methods with no starvation or electric shocks.
Gentle harvesting produces mucin with the highest bioactive peptide levels for cosmetic and pharmaceutical use.
Transparency
This ethical approach, along with video monitoring, sets our brand apart as a leader in sustainable and cruelty-free products.
Certifications are Key
Acquiring certifications from P.E.T.A. and Leaping Bunny provides gold standard levels of cruelty-free production.
COSMOS for organic feed.
ECOCERT for responsible sourcing and humane handling.
ISO 9001/HACCP for quality management audits.
ISO 22716 certification for handling of products.
CoA Certificates of Analysis for transparency.
(GMP) Good Manufacturing Practices from sourcing to storage.
Each certification guides us into the emerging pharmaceutical market.
What is SNAIL MUCIN?
Cosmetic Uses
​
Snail mucin used in cosmetics for anti-aging components.
Allantoin provides anti-inflammatory uses as a moisturizer.
Glycolic Acid used as an exfoliant.
Pharmaceutical Uses
Scar reduction:
Incision and burn wounds.
Acne scarring.
Potential for relief from eczema, rosacea, and dermatitis.
Reduces infection risk and inflammation.
Drug delivery vehicle:
Early research shows promising as a carrier with targeted release, for diabetes treatments, and targeted cancer therapies.
Bio adhesive properties show promise in gastrointestinal applications and wound healing.
Crohn’s research is a target for oral applications.
Anti-tumor & regenerative potential:
Some peptides show metastasis and have slowed cancer cell migration.
Hundreds of peptides have not been identified yet!
Potential breast cancer evidence:
Shows promise of reduced viability of TNBC cells in lab dishes.
Also enhances the effectiveness of chemotherapy drugs by sensitizing TNBC cells.
Potential:
Will lead to novel wound dressings.
Bio adhesives and regenerative biomaterials.
Biodegradable plastic wraps.
​
Links to Studies
https://www.sciencedirect.com/science/article/pii/S1742706125003307
https://pmc.ncbi.nlm.nih.gov/articles/PMC8542881/
https://mcpress.mayoclinic.org/living-well/snail-mucin-for-skincare/
https://www.webmd.com/beauty/what-is-snail-mucin
https://www.wwno.org/npr-news/2023-09-13/the-secrets-of-snail-mucus-according-to-a-biochemist
https://pubmed.ncbi.nlm.nih.gov/40285482/
​
​
MARKET PROJECTIONS
2025 MARKET SIZE FOR COSMETIC MUCIN
$989.4 MILLION (USD)
2036 PROJECTION
$3.1 BILLION (USD)
CAGR 12.1% - COMPOUND ANNUAL GROWTH RATE
Snail mucin is the fastest growing single ingredient in prestige skincare.
Mucin out-paces hyaluronic acid, retinol, and other peptides.
​
https://www.futuremarketinsights.com/reports/snail-mucin-market
In 2021, AmorePacific acquired 38.4% of the leading mucin producer and brand in Korea, COSRX for $567.3 million.
Investment Opportunity
Seed Round One - Series A
D & D BioTech Farms, LLC is divided into 500,000 common units.
~~ FRIENDS AND FAMILY INITIAL OFFER ~~
​
50,000 member units released at $10.00 per unit.
​
10% of D & D BioTech Farms, LLC raises $500,000.00 to get into the production/prototype phase.
This sets the valuation of this agricultural/biotech start up,
at a very modest $5 million dollars.
Seed Round Two - Series B
Restructuring to Corporation dividing priority and common stocks.
Priority shares released based on actual valuation of between $40 - $60 million.
These priority shares will be released at between $80 - $120.00 per share.
15% of D & D BioTech Farms, LLC will raise between $6 to $9 million to start Series B,
and renovate the food/pharma grade manufacturing facilities needed.
We would enjoy sitting with you in person, phone, or through video chat.
We can dive into the business plan or chat about snails.
Call / Text if you are interested, or email us at
513.307.8411
Our Commitment
D & D BioTech Farms stands at the forefront of ethical biotechnology, ensuring high-quality mucin production while maintaining a streamlined manufacturing approach.
Quality
Consistency Matters
Our lab-grown snails are bred with precision to deliver consistent, high-quality mucin. Each batch undergoes rigorous quality checks, ensuring our clients receive the finest products for their needs.
Sustainability
Environmental Focus
With a zero-waste policy, we maximize resource use by converting snail meat into escargot or animal feed and recycling shells for compost. Our approach ensures every aspect of our farming supports sustainability.
Cruelty-Free
Ethical Practices
Our harvesting methods are designed to be gentle and humane, ensuring no harm to the snails. We prioritize their well-being at every stage, reinforcing our commitment to cruelty-free practices.
Innovation
Leading Edge
Continuous innovation drives us forward. We are dedicated to enhancing our processes to further improve sustainability and product quality, setting gold standards in the heliciculture field.
